Cis-(1S,3S)-6-[(3E,5E,7E,9E,11E)-12-[(3S,8R,9S)-9-[(1E,3E)-4-[(1R,4R,6S)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-2-methylbuta-1,3-dienyl]-3,5,6-trimethyl-3-[(4R,8R)-4,8,12-trimethyltridecyl]-2,8,9,10-tetrahydro-1H-pyrano[3,2-f]chromen-8-yl]-3,7-dimethyltrideca-1,3,5,7,9,11-hexaenylidene]-1,5,5-trimethylcyclohexane-1,3-diol
C69H104O6 — CID 162873844
Data last refreshed: (MolForge compound catalog, from PubChem)
About Cis-(1S,3S)-6-[(3E,5E,7E,9E,11E)-12-[(3S,8R,9S)-9-[(1E,3E)-4-[(1R,4R,6S)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-2-methylbuta-1,3-dienyl]-3,5,6-trimethyl-3-[(4R,8R)-4,8,12-trimethyltridecyl]-2,8,9,10-tetrahydro-1H-pyrano[3,2-f]chromen-8-yl]-3,7-dimethyltrideca-1,3,5,7,9,11-hexaenylidene]-1,5,5-trimethylcyclohexane-1,3-diol
Cis-(1S,3S)-6-[(3E,5E,7E,9E,11E)-12-[(3S,8R,9S)-9-[(1E,3E)-4-[(1R,4R,6S)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-2-methylbuta-1,3-dienyl]-3,5,6-trimethyl-3-[(4R,8R)-4,8,12-trimethyltridecyl]-2,8,9,10-tetrahydro-1H-pyrano[3,2-f]chromen-8-yl]-3,7-dimethyltrideca-1,3,5,7,9,11-hexaenylidene]-1,5,5-trimethylcyclohexane-1,3-diol (PubChem CID 162873844) has the molecular formula C69H104O6 and a molecular weight of 1029.58 g/mol. Its IUPAC name is cis-(1S,3S)-6-[(3E,5E,7E,9E,11E)-12-[(3S,8R,9S)-9-[(1E,3E)-4-[(1R,4R,6S)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-2-methylbuta-1,3-dienyl]-3,5,6-trimethyl-3-[(4R,8R)-4,8,12-trimethyltridecyl]-2,8,9,10-tetrahydro-1H-pyrano[3,2-f]chromen-8-yl]-3,7-dimethyltrideca-1,3,5,7,9,11-hexaenylidene]-1,5,5-trimethylcyclohexane-1,3-diol.
Molecular Properties
| Compound Name | Cis-(1S,3S)-6-[(3E,5E,7E,9E,11E)-12-[(3S,8R,9S)-9-[(1E,3E)-4-[(1R,4R,6S)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-2-methylbuta-1,3-dienyl]-3,5,6-trimethyl-3-[(4R,8R)-4,8,12-trimethyltridecyl]-2,8,9,10-tetrahydro-1H-pyrano[3,2-f]chromen-8-yl]-3,7-dimethyltrideca-1,3,5,7,9,11-hexaenylidene]-1,5,5-trimethylcyclohexane-1,3-diol |
|---|---|
| PubChem CID | 162873844 |
| Molecular Formula | C69H104O6 |
| Molecular Weight | 1029.58 g/mol |
| Exact Mass | 1028.78 |
| IUPAC Name | cis-(1S,3S)-6-[(3E,5E,7E,9E,11E)-12-[(3S,8R,9S)-9-[(1E,3E)-4-[(1R,4R,6S)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-2-methylbuta-1,3-dienyl]-3,5,6-trimethyl-3-[(4R,8R)-4,8,12-trimethyltridecyl]-2,8,9,10-tetrahydro-1H-pyrano[3,2-f]chromen-8-yl]-3,7-dimethyltrideca-1,3,5,7,9,11-hexaenylidene]-1,5,5-trimethylcyclohexane-1,3-diol |
| SMILES | C/C(C=C=C1C(C)(C)C[C@H](O)C[C@]1(C)O)=C\C=C\C(C)=C\C=C\C=C(/C)[C@@H]1Oc2c(C)c(C)c3c(c2C[C@H]1/C=C(C)/C=C/[C@]12O[C@@]1(C)C[C@H](O)CC2(C)C)CC[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O3 |
| InChI | InChI=1S/C69H104O6/c1-46(2)24-20-26-48(4)28-21-29-49(5)31-23-37-66(15)38-36-58-59-41-55(40-51(7)35-39-69-65(13,14)43-57(71)45-68(69,17)75-69)61(73-62(59)53(9)54(10)63(58)74-66)52(8)32-19-18-25-47(3)27-22-30-50(6)33-34-60-64(11,12)42-56(70)44-67(60,16)72/h18-19,22,25,27,30,32-33,35,39-40,46,48-49,55-57,61,70-72H,20-21,23-24,26,28-29,31,36-38,41-45H2,1-17H3/b19-18+,27-22+,39-35+,47-25+,50-30+,51-40+,52-32+/t34?,48-,49-,55-,56+,57-,61+,66+,67+,68+,69-/m1/s1 |
| InChIKey | VRWPVBPKEBIXMP-HTQQNCBWSA-N |
| XLogP | 16.92 |
| TPSA | 91.68 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 75 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1029.58 |
| LogP ≤ 5 | 16.92 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'polyene', 'substructure': 'N/A'}, {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162873844 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.